Perceptive Advisors LLC 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:50 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Perceptive Advisors LLC | 2,812,665 3.800% |
-1,209,401 (-30.07%) |
Filing |
| 2024-01-29 4:53 pm Purchase |
2024-01-18 | 13G | Viridian Therapeutics, Inc. VRDN |
Perceptive Advisors LLC | 4,022,066 6.700% |
4,022,066 (New Position) |
Filing |